FDA approves new sunscreen ingredient
The FDA has approved bemotrizinol, a sunscreen ingredient previously used in Europe and Asia, for use in the U.S. The compound provides broad-spectrum protection against both UVA and UVB rays and has a strong safety record based on two decades of global use. Its approval is expected to lead to more effective and user-friendly sunscreen products, potentially increasing public use and improving skin cancer prevention.
The FDA approved a new sunscreen ingredient, bemotrizinol, which has been used in Europe and Asia for years.
The ingredient offers broad protection against both UVA and UVB rays and may lead to more effective and user-friendly sunscreens.
This approval supports public health by providing safer, more trusted options for sun protection, encouraging better sun safety habits.
upbeatBytes summarizes in its own words and links to the original publisher — it doesn't host the article.